CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2019; 03(02): 089-097
DOI: 10.1055/s-0039-1694091
Original Article
Indian Society of Vascular and Interventional Radiology

Vascular Redistribution for SIRT—A Quantitative Assessment of Treatment Success and Long-Term Analysis of Recurrence and Survival Outcomes

Philip Borg
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Jen Jou Wong
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Nicholas Lawrance
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Amarjot Chander
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Jill Tipping
2   Medical Physics & Engineering Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Jon Bell
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Damian Mullan
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Prakash Manoharan
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Steve Jeans
2   Medical Physics & Engineering Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
,
Jeremy Lawrance
1   Radiology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom
› Author Affiliations
Further Information

Publication History

Received: 20 February 2019

Accepted after revision: 27 May 2019

Publication Date:
21 August 2019 (online)

Abstract

Aim Flow redistribution is not uncommonly performed as a treatment strategy to optimize delivery of radioembolization particles to the liver. We quantitatively evaluated the effect of vessel embolization to promote flow redistribution when performing selective internal radiation therapy (SIRT) for liver metastases, and assessed long-term outcomes of treatment.

Materials and Methods One hundred and fifty-eight SIRT procedures over an 8-year period were retrospectively reviewed. Twenty-three patients who underwent partial/whole embolization of the left hepatic artery were compared to a control group of 18 patients who did not receive any hepatic embolization as part of their work up. Counts were measured for each patient on both the post-99mTcMAA injection, and the post-90Y microspheres injection imaging. Recurrence and survival rates were also measured.

Results A statistically significant shift in the right:left ratio between planning and treatment procedures was seen in patients who had vessel embolization in favor of the embolized lobe (p = 0.014). There was no significant difference in the time to recurrence in the embolized lobes versus the nonembolized lobes. No significant difference in overall survival was detected between the two cohorts.

Conclusion To facilitate safe whole liver treatment, it is sometimes necessary to partially or completely occlude main or accessory hepatic arteries. This study shows that the success of flow redistribution strategies can be quantitatively measured, and there is no adverse impact on time to recurrence or overall survival outcomes.

 
  • References

  • 1 Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 2006; 17 (08) 1251-1278
  • 2 Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 2006; 17 (09) 1425-1439
  • 3 Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006; 17 (10) 1571-1593
  • 4 Kennedy A, Nag S, Salem R. et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68 (01) 13-23
  • 5 Young JY, Rhee TK, Atassi B. et al. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol 2007; 18 (11) 1375-1382
  • 6 Braat AJ, Smits ML, Braat MN. et al. 90. Y hepatic radioembolization: an update on current practice and recent developments. J Nucl Med 2015; 56 (07) 1079-1087
  • 7 Vesselle G, Petit I, Boucebci S, Rocher T, Velasco S, Tasu JP. Radioembolization with yttrium-90 microspheres work up: practical approach and literature review. Diagn Interv Imaging 2015; 96 (06) 547-562
  • 8 Donato P, Coelho P, Rodrigues H. et al. Normal vascular and biliary hepatic anatomy: 3D demonstration by multidetector CT. Surg Radiol Anat 2007; 29 (07) 575-582
  • 9 Ackerman NB, Hechmer PA, Kondi ES. The blood supply of experimental liver metastases. V. Increased tumor perfusion with epinephrine. Am J Surg 1980; 140 (05) 625-631
  • 10 van den Hoven AF, Smits ML, de Keizer B, van Leeuwen MS, van den Bosch MA, Lam MG. Identifying aberrant hepatic arteries prior to intra-arterial radioembolization. Cardiovasc Intervent Radiol 2014; 37 (06) 1482-1493
  • 11 Tohma T, Cho A, Okazumi S. et al. Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery. Radiology 2005; 237 (01) 361-365
  • 12 McWilliams JP, Kee ST, Loh CT, Lee EW, Liu DM. Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes. Cardiovasc Intervent Radiol 2011; 34 (04) 786-792
  • 13 Chuang VP, Wallace S. Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms. Radiology 1980; 135 (02) 295-299
  • 14 Gunji H, Cho A, Tohma T. et al. The blood supply of the hilar bile duct and its relationship to the communicating arcade located between the right and left hepatic arteries. Am J Surg 2006; 192 (03) 276-280
  • 15 Bilbao JI, Garrastachu P, Herráiz MJ. et al. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol 2010; 33 (03) 523-531
  • 16 Karunanithy N, Gordon F, Hodolic M. et al. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy. Cardiovasc Intervent Radiol 2011; 34 (02) 287-294
  • 17 Spreafico C, Morosi C, Maccauro M. et al. Intrahepatic flow redistribution in patients treated with radioembolization. Cardiovasc Intervent Radiol 2015; 38 (02) 322-328
  • 18 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (01) 159-174
  • 19 NHS Improvement National tariff payment system 2018–19. Available at https://improvement.nhs.uk/resources/national-tariff-1719/#h2-tariff-documents Accessed May 14, 2019
  • 20 Bengmark S, Rosengren K. Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am J Surg 1970; 119 (06) 620-624
  • 21 Civalleri D, Scopinaro G, Simoni G. et al. Starch microsphere-induced arterial flow redistribution after occlusion of replaced hepatic arteries in patients with liver metastases. Cancer 1986; 58 (09) 2151-2155
  • 22 Abdelmaksoud MH, Louie JD, Kothary N. et al. Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. J Vasc Interv Radiol 2011; 22 (10) 1355-1362
  • 23 Lauenstein TC, Heusner TA, Hamami M. et al. Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries. RoFo Fortschr Geb Rontgenstr Nuklearmed 2011; 183 (11) 1058-1064